News and Publications - 이뮨온시아

A phase I study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors

A phase I study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors | SpringerLink

By admin| 2021/07/27|Categories: News and Publications|0 Comments

ImmuneOncia and 3D Medicines Signed Exclusive License Agreement to Develop, Manufacture and Commercialize IMC-002 in Greater China

[English News] ImmuneOncia and 3D Medicines Signed Exclusive License Agreement to Develop, Manufacture and Commercialize IMC-002 in Greater China (prnewswire.com) [Korean News] 유한양행이 점찍은 이뮨온시아, '5400억원' 항암신약 기술수출 - 머니투데이 (mt.co.kr)

By admin| 2021/04/01|Categories: News and Publications|0 Comments

재무상태표 공고(제5기)

By admin| 2021/03/31|Categories: News and Publications|0 Comments

외부감사인 선임 공고(제6기)

By admin| 2021/02/18|Categories: News and Publications|0 Comments

외부감사인 선임 공고(제5기)

By admin| 2021/02/05|Categories: News and Publications|0 Comments

이뮨온시아·레고캠바이오, 면역조절 항체 결합체 신약 후보 발굴 맞손

[Korean News] https://www.mk.co.kr/news/stock/view/2020/12/1268313/

By admin| 2020/12/10|Categories: News and Publications|0 Comments